UCLE: the cashflow

MyFinsight

For the quarter ending 2025-09-30, UCLE had $7,418 increase in cash & cash equivalents over the period.

Unit: Dollar

Cash Flow	2025-09-30	2025-03-31
Depreciation and amortization	720	360
Issuance of common stock for compensation and services	525,789	56,100
Issuance of common stock for debt	8,333	-
Accounts receivable	68,959	-290,413
Note receivable	7,770	-
Inventories	-45,598	214,107
Prepaid	0	-10,000
Accounts payable	-42,410	-3,630
Accrued liabilities	-23,375	54,553
Customer deposits	-130,917	-
Net loss	-60,444	-560,232
Incentive expense	24,000	-
Financing costs	0	-
Debt discount amortization	-	0
Loss on deconsolidation	0	-
Issuance of warrants for services	-	-394,999
Deferred revenue	-	0
Accounts payable - related parties	0	0
Customer deposits	-	-120,942
Accrued compensation - officers	0	0
Net cash used in operating activities	-3,492	-92,486
Net borrowings (repayments) under lines of credit	100,000	0
Proceeds from issuance of note payable shareholder	78,300	-
Repayments of note payable shareholder	42,135	31,865
Proceeds from notes payable	38,000	12,000
Repayments of notes payable	126,430	0
Treasury stock	7,425	-
Proceeds from issuance of common stock	50,000	50,000
Cash dividends paid	29,400	-
Net cash provided by financing activities	10,910	30,135
Employee advance	0	-
Note receivable	0	0
Net cash used in investing activities	0	0
Net increase (decrease) in cash	7,418	-62,351
Cash and cash equivalents at beginning of period	130,840	-
Cash and cash equivalents at end of period	75,907	-

Unit: Dollar